ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

13 links0 made here, not in the record23 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT04546399A Study to CompareBlinatumomab Alone toBlinatumomab With Nivolumabin Patients Diagnosed WithFirst Relapse B-Cell AcuteLymphoblastic Leukemia(B-ALL)National Cancer Institute (NCIPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Version of 2026-11-12CONDITIONSDown SyndromeThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionBurkitt LymphomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSAsparaginase erwinia chrysa…Intervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundBlinatumomabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedCalaspargase pegolIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundCytarabineIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundDexamethasoneIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundHydrocortisone hemisuccinateEntry “Hydrocortisone Sodium Succinat…›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundMercaptopurineIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundMethotrexateIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundNivolumabIntervention entry›Nov 2 · Claude Opus 5.5 · TestedNov 18 · Rule based · BackgroundTestedPegaspargaseIntervention entry›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundVincristineEntry “Vincristine Sulfate”, read by …›Nov 2 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Asparaginase erwinia chrysanthemi

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Asparaginase Erwinia chrysanthemi”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Background
Background · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2Asparaginase erwinia chrysanthemiClaude Opus 5.5BackgroundCurrent
Nov 2BlinatumomabClaude Opus 5.5TestedCurrent
Nov 2Calaspargase pegolClaude Opus 5.5BackgroundCurrent
Nov 2CytarabineClaude Opus 5.5BackgroundCurrent
Nov 2DexamethasoneClaude Opus 5.5BackgroundCurrent
Nov 2Hydrocortisone hemisuccinateClaude Opus 5.5BackgroundCurrent
Nov 2MercaptopurineClaude Opus 5.5BackgroundCurrent
Nov 2MethotrexateClaude Opus 5.5BackgroundCurrent
Nov 2NivolumabClaude Opus 5.5TestedCurrent
Nov 2PegaspargaseClaude Opus 5.5BackgroundCurrent
Nov 2VincristineClaude Opus 5.5BackgroundCurrent
Nov 12The record itselfClinicalTrials.gov recordVersion of 2026-11-12Record change
Nov 18Asparaginase erwinia chrysanthemiRule based · role ruleBackgroundAgrees
Nov 18BlinatumomabRule based · role ruleTestedAgrees
Nov 18Calaspargase pegolRule based · role ruleBackgroundAgrees
Nov 18CytarabineRule based · role ruleBackgroundAgrees
Nov 18DexamethasoneRule based · role ruleBackgroundAgrees
Nov 18Hydrocortisone hemisuccinateRule based · role ruleBackgroundAgrees
Nov 18MercaptopurineRule based · role ruleBackgroundAgrees
Nov 18MethotrexateRule based · role ruleBackgroundAgrees
Nov 18NivolumabRule based · role ruleBackgroundOverridden
Nov 18PegaspargaseRule based · role ruleBackgroundAgrees
Nov 18VincristineRule based · role ruleBackgroundAgrees
As of nowDown SyndromeRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.